Showing results (521-530 of 671) with videos related to

Sort By:
Pageof 68
Molecular Cancer Therapeutics|June 10, 2010
Serum signature of hypoxia-regulated factors is associated with progression after induction therapy in head and neck squamous cell cancerLauren Averett Byers, F Christopher Holsinger, Merrill S Kies, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 8, 2018
Multiregion gene expression profiling reveals heterogeneity in molecular subtypes and immunotherapy response signatures in lung cancerWon-Chul Lee, Lixia Diao, Jing Wang, et al.
Journal of Thoracic Disease|July 10, 2020
Genomic assessment distinguishes intrapulmonary metastases from synchronous primary lung cancersErin M Corsini, Jinliang Wang, Chia-Chin Wu, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 28, 2016
The International Association for the Study of Lung Cancer Consensus Statement on Optimizing Management of EGFR Mutation-Positive Non-Small Cell Lung Cancer: Status in 2016Daniel S W Tan, Sue S Yom, Ming S Tsao, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 4, 2020
TRPS1: a highly sensitive and specific marker for breast carcinoma, especially for triple-negative breast cancerDi Ai, Jun Yao, Fei Yang, et al.
American Journal of Respiratory and Critical Care Medicine|March 22, 2019
Driver Mutations in Normal Airway Epithelium Elucidate Spatiotemporal Resolution of Lung CancerHumam Kadara, Smruthy Sivakumar, Yasminka Jakubek, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 25, 2019
Hybrid oncocytic/chromophobe renal tumors are molecularly distinct from oncocytoma and chromophobe renal cell carcinomaRoberto Ruiz-Cordero, Priya Rao, Lerong Li, et al.
The Journal of Investigative Dermatology|April 19, 2020
T-Cell Repertoire in Combination with T-Cell Density Predicts Clinical Outcomes in Patients with Merkel Cell CarcinomaMaya Farah, Alexandre Reuben, Ivelina Spassova, et al.
Cancer Research Communications|June 27, 2024
Tumor-Immune Signatures of Treatment Resistance to Brentuximab Vedotin with Ipilimumab and/or Nivolumab in Hodgkin LymphomaEdgar Gonzalez-Kozlova, Hsin-Hui Huang, Opeyemi A Jagede, et al.
Pageof 68